Olivier Godefroy
Neurology — Centre Hospitalier Universitaire Amiens-Picardie, France
Olivier Godefroy
LeadR Profile
Neurology
Subspecialties: Nephrology - Transplantation - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 452
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Development of a Prognostic Model for Poststroke Dementia Using Multiple International Cohorts: A STROKOG Collaboration Study. dementia, stroke, sex, neurology | Neurology | 2026 | 0 |
| Consensus-Harmonized Neuropsychological Assessment for Vascular Cognitive Impairment and Dementia. dementia, cognitive dysfunction, clinical medicine, cognition disorders | JAMA Netw Open | 2025 | 1 |
| Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria. dementia, neuroimaging, cognitive dysfunction, biomarkers, cognition disorders, diagnosis, nervous system diseases | JAMA Neurol | 2025 | 0 |
| Verbal fluency in bilingual Lebanese adults: Is the prominent language advantage due to executive processes, language processes, or both? aged, language, semantics, cluster analysis | Appl Neuropsychol Adult | 2023 | 4 |
| Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers. dementia, blood, alzheimer disease, probability, brain, phenotype, cohort studies, cognitive dysfunction, predictive value of tests, biomarkers, amyloidosis, cognition disorders, prevalence, amyloid, nervous system diseases | JAMA Neurol | 2025 | 12 |
Clinical Studies 24
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 16
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| An Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer s Disease (MCI to Mild Dementia Due to AD) 2024-518006-40-00 — dementia, safety, alzheimer disease | Phase 3 | Active not recruiting | 2025 |
| An Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer s Disease (MCI to Mild Dementia Due to AD) 2024-518008-33-00 — dementia, safety, alzheimer disease | Phase 3 | Active not recruiting | 2025 |
| Dynamic Causal Modeling of Neuromodulation of Action Speed Via Targeted TMS EEG NCT07468032 — stroke, brain, rehabilitation, recycling, healthy volunteers, reaction time, therapeutics, wounds and injuries | N/A | Recruiting | 2026 |
| Genetic Variants of Annexin A2 and Cryptogenic Stroke NCT06880107 — genes, annexin a2, annexins, blood, ischemic stroke, stroke, fibrinolysis | N/A | Recruiting | 2025 |
| The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task NCT05875103 — stroke, semantics, brain, language tests, work, research, linguistics, vocabulary, speech, speech disorders | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map